Abstract:Amyloid-β (Aβ) is a peptide that undergoes self-assembly into amyloid fibrils, which compose the hallmark plaques observed in Alzheimer's disease (AD). TAR DNA-binding protein 43 (TDP-43) is a protein with mislocalization and aggregation implicated in amyotrophic lateral sclerosis and other neurodegenerative diseases. Recent work suggests that TDP-43 may interact with Aβ, inhibiting the formation of amyloid fibrils and worsening AD pathology, but the molecular details of their interaction remain unknown. Using all-atom discrete molecular dynamics simulations, we systematically investigated the direct molecular interaction between Aβ and TDP-43. We found that Aβ monomers were able to bind near the flexible nuclear localization sequence of the N-terminal domain (NTD) of TDP-43, adopting β-sheet rich conformations that were promoted by the interaction. Furthermore, Aβ associated with the nucleic acid binding interface of the tandem RNA recognition motifs of TDP-43 via electrostatic interactions. Using the computational peptide array method, we found the strongest C-terminal domain interaction with Aβ to be within the amyloidogenic core region of TDP-43. With experimental evidence suggesting that the NTD is necessary for inhibiting Aβ fibril growth, we also simulated the NTD with an Aβ40 fibril seed. We found that the NTD was able to strongly bind the elongation surface of the fibril seed via extensive hydrogen bonding and could also diffuse along the lateral surface via electrostatic interactions. Our results suggest that TDP-43 binding to the elongation surface, thereby sterically blocking Aβ monomer addition, is responsible for the experimentally observed inhibition of fibril growth. We conclude that TDP-43 may promote Aβ toxicity by stabilizing the oligomeric state and kinetically delaying fibril maturation.

TGF-β Induces TIAF1 Self-Aggregation Via Type II Receptor-Independent Signaling That Leads to Generation of Amyloid Β Plaques in Alzheimer's Disease.

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

[P4–126]: Δ‐secretase–cleaved TAU STIMULATES Aβ PRODUCTION VIA ACTIVATING STAT1‐BACE1 PATHWAY IN ALZHEIMER's DISEASE

Δ-Secretase-cleaved Tau Stimulates Aβ Production Via Upregulating STAT1-BACE1 Signaling in Alzheimer's Disease.

Self-aggregating TIAF1 in Lung Cancer Progression

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer'S Disease and Appswe/Ps1de9 Double Transgenic Mice Brains

Progress of the Action of TGF-β in Alzheimer's Disease

Inhibition of Tissue Transglutaminase Promotes Aβ-induced Apoptosis in SH-SY5Y Cells

TGF-β1 protection against Aβ1-42-induced neuroinflammation and neurodegeneration in rats

A monomer induces phosphorylation of Tau at Ser-214 through 2AR-PKA-JNK signaling pathway

TDP-43 Promotes Amyloid-Beta Toxicity by Delaying Fibril Maturation via Direct Molecular Interaction

Regulatory Role Of Golgi Brefeldin A Resistance Factor-1 In Amyloid Precursor Protein Trafficking, Cleavage And A Beta Formation

BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer's Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology.

Amyloid β-Induced Redistribution of Transcriptional Factor EB and Lysosomal Dysfunction in Primary Microglial Cells.

Aβ1-16 Can Aggregate and Induce the Production of Reactive Oxygen Species, Nitric Oxide, and Inflammatory Cytokines.

The role of transforming growth factor β1 /Smad pathway in Alzheimer's disease inflammation pathology

Amyloid-β Plaques Enhance Alzheimer's Brain Tau-Seeded Pathologies by Facilitating Neuritic Plaque Tau Aggregation

Traumatic Brain Injury Triggers APP and Tau Cleavage by Delta-Secretase, Mediating Alzheimer's Disease Pathology.

Beta-Secretase-1 Elevation In Transgenic Mouse Models Of Alzheimer'S Disease Is Associated With Synaptic/Axonal Pathology And Amyloidogenesis: Implications For Neuritic Plaque Development

Involvement Of Receptor Tyrosine Kinase Tyro3 In Amyloidogenic App Processing And Beta-Amyloid Deposition In Alzheimer'S Disease Models